San Francisco Sentry Investment Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $5K | Hold |
26
| – | – | ﹤0.01% | 576 |
|
|
2021
Q1 | $4K | Hold |
26
| – | – | ﹤0.01% | 625 |
|
|
2020
Q4 | $4K | Hold |
26
| – | – | ﹤0.01% | 591 |
|
|
2020
Q3 | $3K | Hold |
26
| – | – | ﹤0.01% | 587 |
|
|
2020
Q2 | $3K | Sell |
26
-167
| -87% | -$19.3K | ﹤0.01% | 577 |
|
|
2020
Q1 | $17K | Buy |
193
+24
| +14% | +$2.11K | 0.01% | 405 |
|
|
2019
Q4 | $18K | Sell |
169
-22
| -12% | -$2.34K | 0.01% | 493 |
|
|
2019
Q3 | $19K | Buy |
191
+176
| +1,173% | +$17.5K | 0.01% | 483 |
|
|
2019
Q2 | $2K | Sell |
15
-207
| -93% | -$27.6K | ﹤0.01% | 784 |
|
|
2019
Q1 | $30K | Sell |
222
-1
| -0.4% | -$135 | 0.01% | 443 |
|
|
2018
Q4 | $22K | Sell |
223
-13
| -6% | -$1.28K | 0.01% | 458 |
|
|
2018
Q3 | $33K | Sell |
236
-427
| -64% | -$59.7K | 0.01% | 433 |
|
|
2018
Q2 | $83K | Buy |
663
+618
| +1,373% | +$77.4K | 0.03% | 334 |
|
|
2018
Q1 | $5K | Hold |
45
| – | – | ﹤0.01% | 771 |
|
|
2017
Q4 | $6K | Hold |
45
| – | – | ﹤0.01% | 743 |
|
|
2017
Q3 | $6K | Buy |
45
+30
| +200% | +$4K | ﹤0.01% | 735 |
|
|
2017
Q2 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 708 |
|
|
2014
Q4 | – | Sell |
-500
| Closed | -$83K | – | 494 |
|
|
2014
Q3 | $83K | Hold |
500
| – | – | 0.04% | 242 |
|
|
2014
Q2 | $78K | Hold |
500
| – | – | 0.04% | 262 |
|
|
2014
Q1 | $76K | Buy |
+500
| New | +$76K | 0.02% | 302 |
|